You will be given a definition of a task first, then an example. Follow the example to solve a new instance of the task.
Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

"Although the story didn't cite the cost of appendectomy emergency or urgent surgery and we wish it had, we nonetheless will give it a satisfactory score because it at least cited what the editorial writer wrote, ""A secondary benefit is the savings to the hospital generated by minimizing staff and anesthesiologist presence late in the evening and during the wee hours of the morning."" As with our harms score above, although the story didn't give absolute numbers, in this case we think it was sufficient for it to report that ""The scientists found no significant difference among the groups in the patients' condition 30 days after surgery or in the length of their operation or hospital stay."" Although the story didn't give absolute numbers, in this case we think it was sufficient for it to report that ""The scientists found no significant difference among the groups in the patients' condition 30 days after surgery or in the length of their operation or hospital stay."" Despite running less than 300 words, this story did an adequate job in explaining the quality of the evidence, including pointing out limitations. No disease-mongering here. The story meets the bare minimum requirement for this criterion in that it at least cited what an editorial stated. The focus of the story was on a study comparing emergency appendectomy with surgery done up to 12 hours later or beyond. This is the whole focus of the story and one we applaud when it begins: ""Appendectomy is the most common emergency surgery in the world, but it doesn't have to be."" There were no claims made about the novelty of this research, and we may have wished for a bit more context on this. Nonetheless, the potential for guiding future care decisions was made clear. Not applicable. Given that the story only pulled excerpts from the journal article and the accompanying editorial, and didn't include any fresh quotes from interviews, we can't be sure of the extent to which it may have been influenced by a news release."
Solution: Some appendicitis cases may not require 'emergency' surgery
Why? The paragraph mentions that "Appendectomy is the most common emergency surgery in the world, but it doesn't have to be." which is considered evidence for the output. Thus, the output is a valid claim.

New input: Though modest, it was the first such price drop in 45 years, according to nonpartisan economic experts at the federal Department of Health and Human Services, who deliver an annual report on the nation's health care spending. The price drop was for retail pharmacy prescriptions, not medications administered in hospitals or doctor's offices. HHS experts said the last time retail prescription drug prices declined was in 1973, when they went down by 0.2%. The price drop comes amid questionable prospects for major legislation to curb prescription drug costs. Nonetheless, it was a nugget of decent news in a sobering, broader report on rising U.S. health care spending. The HHS report found that spending on prescription medicines at pharmacies accounted for 9% of the total $3.6 trillion national health care tab in 2018. Total U.S. health care spending grew by 4.6% last year, averaging $11,172 per person. In the real world, U.S. spending is concentrated on the sickest patients, with 5% of the population accounting for half of costs. Because of strong overall economic growth last year, health care spending as a share of the national economy declined slightly, from 17.9% in 2017 to 17.7%, the report found. Legislation pending in Congress to curb drug costs would mainly benefit older people on Medicare, who are the biggest consumers of medicines. House Speaker Nancy Pelosi is forging ahead with a floor vote next week on her bill authorizing Medicare to negotiate prices for the costliest drugs, including insulin. Under her bill, private insurance plans would be able to get Medicare's prices as well. But President Donald Trump and Republicans in Congress are solidly opposed to Medicare negotiations. Instead Trump is backing a bipartisan Senate bill that would require drugmakers to pay rebates to Medicare if they hike prices above inflation. As a candidate Trump had called for allowing Medicare to negotiate directly. Both bills would cap what Medicare recipients must pay annually in out-of-pocket costs for their prescriptions. The HHS report made no forecast of future prescription drug prices. It's unclear if the 1% price decline seen last year may be the beginning of a sustained trend or was merely a temporary pullback by drug companies getting pummeled by Trump and lawmakers of both parties. Thursday's report found that nearly 9 out of 10 prescriptions dispensed are for generic drugs, which puts downward pressure on prices. Even though prices of brand-name drugs increased more moderately, they still accounted for most of the spending on prescriptions nearly 79%. The government's findings on prices for brand-name drugs dovetailed with an analysis earlier this year by The Associated Press. In the first seven months of 2019, drugmakers raised list prices for brand-name prescription medicines by a median of 5%, the AP found. That was down from about 9% or 10% over those months the prior four years. The AP's findings suggest that an easing in drug prices may continue this year. Reducing prescription drug costs remains one of the top priorities for consumers. The White House claims that Trump has already delivered historic price cuts, but a recent Gallup poll found that 66% of adults believe the president has made little or no progress. The government study was published online by the journal Health Affairs.
Solution:
US report: Prescription drug prices down slightly last year.